靶点针对疾病信息20(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Estrogen receptor beta (ESR2)
INDICATI
Approved Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Approved Cushing syndrome [ICD-11: 5A70]
INDICATI
Approved Menopausal disorder [ICD-11: GA30]
INDICATI
Approved Vasomotor/allergic rhinitis [ICD-11: CA08]
INDICATI
Phase 3 Hepatitis virus infection [ICD-11: 1E50-1E51]
INDICATI
Phase 3 Hyper-lipoproteinaemia [ICD-11: 5C80]
INDICATI
Phase 2/3 Prostate cancer [ICD-11: 2C82]
INDICATI
Phase 2 Prostate hyperplasia [ICD-11: GA90]
INDICATI
Withdrawn from market Trematode disease [ICD-11: 1F8Y]
INDICATI
Discontinued in Phase 3 Low bone mass disorder [ICD-11: FB83]
INDICATI
Discontinued in Phase 1 Thrombocytopenia [ICD-11: 3B64]
INDICATI
Investigative Herpes simplex infection [ICD-11: 1F00]
INDICATI
Investigative Postoperative inflammation [ICD-11: 1A00-CA43]